To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Intravenous Tranexamic Acid on Perioperative Blood Loss in Total Knee Arthoplasty

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
February 2025

Intravenous Tranexamic Acid on Perioperative Blood Loss in Total Knee Arthoplasty

Vol: 307| Issue: 2| Number:5| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

The Effect of Intravenous Tranexamic Acid on Perioperative Blood Loss, Transfusion Requirements, Verticalization, and Ambulation in Total Knee Arthroplasty: A Randomized Double-Blind Study.

Medicina (Kaunas) . 2024 Jul 21;60(7):1183.

Contributing Authors:
G Jovanovic M Lukic-Sarkanovic F Lazetic T Tubic D Lendak A Uvelin

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Ninety-six patients undergoing primary total knee arthroplasty (TKA) were randomized to receive intravenous tranexamic acid (TXA) at two time points (n=48) or a placebo of 0.9% saline solution (n=48). The primary outcome was perioperative blood loss. Secondary outcomes included transfusion requirements, time to verticalization, and time to ambulation. Outcomes were assessed up to postoperative day...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue